This site is intended for US Residents only.

Please select all that apply:

Person with Hemophilia A
Healthcare Professional
Advocacy Professional/Volunteer
Caregiver of a person
with Hemophilia A
Industry Professional
Home care/speciality
pharmacy employee
Password must be at least six characters. Show Password
You must be 13 years or older to register.

Your kit will contain:

  • An ELOCTATE Product Guide
  • A Doctor Discussion Guide
  • Steps to start on ELOCTATE
  • An Informational Video and Tablet Case

Your bag will contain:

  • Four ballistic nylon removable zipper compartments
  • A sharps container
  • A clear protective pouch to protect medical paperwork
  • Micro8 treatment monitoring application instructions

I authorize Bioverativ and companies working with Bioverativ to use my personal information including health information provided herein or provided by me in the future, to provide me with information about, or ask me about my experience with or thoughts about products, services, and programs that Bioverativ offers or sponsors. I understand and agree that any information I provide may be used by Bioverativ to help develop products, services, and programs. I understand and agree that Bioverativ, and companies working with Bioverativ, may contact me by mail, email, fax, and/or telephone. This may include calls and text messages made using an automatic telephone dialing system or a prerecorded voice at the telephone number(s) provided.

We may also share such Personal Data with regulatory authorities or contact you to conduct market research. Your Personal Data will be processed and stored in electronic databases controlled by or on behalf of Bioverativ. We will not sell or transfer your Personal Data to any unrelated third party for marketing purposes without your expressed permission.

You must be thirteen (13) years or older to enroll. If you are aged 13 to 18, you should get your parent's or guardian's permission before providing your personal health information.

To learn more about how your personal information is used or if you decide that you no longer want to receive information about Bioverativ products and services, please visit bioverativ.com/privacy-policy.aspx.

Indications and Important Safety Information

Indications

ELOCTATE [Antihemophilic Factor (Recombinant), Fc Fusion Protein] is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. ELOCTATE is not indicated for the treatment of von Willebrand disease.

Important Safety Information

Do not use ELOCTATE if you have had an allergic reaction to it in the past.

Tell your healthcare provider if you have or have had any medical problems, take any medicines, including prescription and non-prescription medicines, supplements, or herbal medicines, have any allergies, are breastfeeding, are pregnant or planning to become pregnant, or have been told you have inhibitors (antibodies) to Factor VIII.

Allergic reactions may occur with ELOCTATE. Call your healthcare provider or get emergency treatment right away if you have any of the following symptoms: difficulty breathing, chest tightness, swelling of the face, rash, or hives.

Your body can also make antibodies called, "inhibitors," against ELOCTATE, which may stop ELOCTATE from working properly.

The most frequently occurring side effects of ELOCTATE are headache, rash, joint pain, muscle pain and general discomfort. These are not all the possible side effects of ELOCTATE. Talk to your healthcare provider right away about any side effect that bothers you or that does not go away, and if bleeding is not controlled after using ELOCTATE.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Please see full Prescribing Information.

©2017 Bioverativ. All rights reserved.